Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Mar 4;17(3):694-695.
doi: 10.1080/21645515.2020.1799670. Epub 2020 Sep 22.

Cost-effectiveness analysis has to consider all available evidence when informing inputs

Fabián P Alvarez  1 , Audrey Petitjean  1 , Joshua Nealon  2 , Rosalind Hollingsworth  3 , Juan Luis López-Belmonte  4
Affiliations
Comment

Cost-effectiveness analysis has to consider all available evidence when informing inputs

Fabián P Alvarez et al. Hum Vaccin Immunother. .
No abstract available

Keywords: Influenza; Spain; cell-based vaccines; cost-effectiveness; egg-based vaccines; quadrivalent influenza vaccine (QIV); vaccination.

PubMed Disclaimer

Comment in

  • Reply to letter from Alvarez et al.
    Ruiz-Aragón J, Gani R, Márquez S, Alvarez P. Ruiz-Aragón J, et al. Hum Vaccin Immunother. 2021 Mar 4;17(3):696-697. doi: 10.1080/21645515.2020.1813485. Epub 2020 Oct 29. Hum Vaccin Immunother. 2021. PMID: 33121349 Free PMC article. No abstract available.

Comment on

References

    1. Ruiz-Aragón J, Gani R, Márquez S, Alvarez P.. Estimated cost-effectiveness and burden of disease associated with quadrivalent cell-based and egg-based influenza vaccines in Spain. Hum Vaccin Immunother. published online February10, 2020;2020:1–7. doi: 10.1080/21645515.2020.1712935. - DOI - PMC - PubMed
    1. Word Health Organization . WHO guide for standardization of economic evaluations of immunization programmes. 2nd ed. Geneva (Switzerland): World Health Organization; 2019. Available at https://www.who.int/immunization/documents/who_ivb_19.10/en/
    1. Mauskopf J, Standaert B, Connolly MP, Culyer AJ, Garrison LP, Hutubessy R, Jit M, Pitman R, Revill P, Severens JL.. Economic Analysis of Vaccination Programs: An ISPOR Good Practices for Outcomes Research Task Force Report. Value in Health. 2018;21:1133–49. doi: 10.1016/j.jval.2018.08.005 - DOI - PubMed
    1. Husereau D, Drummond M, Petrou S, Carswell C, Moher D, Greenberg D, Augustovski F, Briggs AH, Mauskopf J, Loder E.. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. BMC Medicine 2013;11:80. doi: 10.1186/1741-7015-11-80 - DOI - PMC - PubMed
    1. Boikos C, Sylvester GC, Sampalis JS, Mansi JA. Relative effectiveness of the cell-cultured quadrivalent influenza vaccine compared to standard, egg-derived quadrivalent influenza vaccines in preventing influenza-like illness in 2017–2018. Clin Infect Dis. 2020; published online April 7, 2020. doi: 10.1093/cid/ciaa371 - DOI - PMC - PubMed

Substances